The first phase of research is being conducted this January and February 2023 and will analyse the amount and distribution of UK canine health research funding over the past decade.
Veterinary associations, societies and charities which support canine health research tend to identify funding priorities aligned with their own strategy and scope, taking account of independent peer review from experts in the field of research.
However, the RVC says that as there are many research funders working independently, some important research topics may be overlooked and separately funded projects can inadvertently overlap in their work.
This study endeavours to investigate these issues and consider how resources are prioritised across different areas of canine research.
Participating stakeholders will be asked their opinions on future research funding and this information will contribute to developing a long-term strategy for not-for-profit UK canine health research.
Thereafter, the aim is to create a pilot consultation process for developing a central prioritisation platform for future collaborative canine research.
The RVC’s says it has already got data and support from several major funders but is keen to maximise the scope of this research, so it is now looking for participation from specialist veterinary societies that fund research, and non-university organisations, such as charities, corporates or independent referral practices which conduct their own in-house canine research.
Dr Alison Skipper, Postdoctoral Researcher into Canine Research Funding within VetCompass at the RVC said: “We are really keen to hear from as many non-profit organisations involved with canine health research funding as possible. The breadth and depth of this data is vital to ensure that our findings accurately reflect this sector."
For more information about how to get involved, please visit https://rvc.uk.com/canine-research-funding-analysis.
VetSurgeon member, Rachel Crowe is asking veterinary surgeons to help with a survey looking at the relationship between vets and drug companies.
The survey forms part of Rachel's dissertation for her MBA, titled: In harmony or out of tune? Perceptual gaps between expectations of vets and supplier.
The survey is being carried out in association with VetSurgeon.org. We've agreed to promote it to VetSurgeon members in return for being able to share the bulk of the results with our members, and, importantly, with all veterinary suppliers. Our hope is that as a result, the time you spend carrying out the survey will help influence the way drug companies do business, and help them give you a better standard of service. In addition, the survey is also being supported by Rachel's employer, Virbac Animal Health, which will have first sight of the results.
As a small thank you, everyone who completes the survey will be entered into a draw for one of 5 Marks and Spencer shopping vouchers.
Thus far, 182 members have already taken part in the survey. If you are one of the few that didn't complete it, please do, as Rachel needs as many completed surveys as possible. If you have only partially completed the survey, you should find that the system has stored your previous answers, so you won't need to start all over again.
To take part, please click here.
Petplan has announced the winners of its 2011 Veterinary Awards.
The awards are to recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Alison Andrew, Petplan's Marketing Manager said: "Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity, on behalf of all pet owners across the UK, to thank the veterinary profession for the outstanding service they provide to our pets.
"This is the 12th year of the awards and this year we received over 2,800 nominations, a record number for the vet awards, which really highlights the high regard that the profession and pet owners have for these awards."
The winners for each category are:
VET OF THE YEARAlison Laurie, Crown Vets - Highlands What really stood out about Alison for the independent panel of judges was her clinical excellence, exceptional ability and compassion towards customers and their pets, all of which were highly praised in her nominations.
VET NURSE OF THE YEARMaria Corcoran, Orwell Veterinary Group - Ipswich Maria's ability to naturally lead by example was a prominent factor for the judges, as well as her ability to always make pet care and comfort her top priority. She also provides great customer service and high clinical standards.
VET SUPPORT STAFF OF THE YEAR Patty Fraser, Loch Leven Equine Practice - KinrossThe independent panel of judges was really impressed by Patty; she is considered to be the 'hub' of the practice and constantly makes a strong contribution to the team in many ways. Her ability to organise and multitask whilst offering excellent customer service is outstanding.
VET PRACTICE OF THE YEAR Emersons Green Veterinary Surgery Ltd - Avon Emersons Green Veterinary Surgery's work to continually educate their customers really stood out for the independent panel of judges. The practice works incredibly hard to provide regular newsletters and updates on their Facebook page, which is run by nurses, whilst maintaining a great level of service for their pets and clients. The practice has also been very successful in helping to re-home dogs.
HMRC has published advice concerning the forthcoming increase in the rate of VAT, from 17.5% to 20% on Tuesday 4th January 2011.
From 4th January, you will need to charge the new 20% VAT rate on all standard-rated sales you make and all retail takings your receive.
The new VAT fraction for the 20 per cent rate is 1/6 (used to calculate the VAT element of standard-rated gross takings).
If your business issues VAT invoices, you must use the new 20 per cent rate for all VAT invoices you issue on or after 4 January, which are issued within 14 days (or longer period that has been agreed with HMRC) of you providing the goods or services.
Supplies that span the rate changeIf you supply goods or services before 4 January 2011, but issue a VAT invoice on or after that date, you can choose to charge VAT at 17.5 per cent.
Continuous supplies of servicesFor a contract that started before 4 January you can choose to charge the old rate, 17.5 per cent, on services actually performed before 4 January, and the new rate of 20 per cent on the value of services actually performed after.
Reclaiming VATFrom 4 January 2011, you may receive VAT invoices with the new 20 per cent rate, as well as VAT invoices with the old 17.5 per cent rate for goods or services you bought before the rate changed. In such cases, you should claim back VAT at the rate shown on the invoice.
Completing a VAT returnThe deadlines for submitting VAT returns remain the same, so you should continue to submit VAT returns in the usual way - whether you send them monthly, quarterly or annually. For returns that span the change in rate, you will need to add together both the VAT on sales charged at 17.5 per cent and those charged at 20 per cent. You then put this total in box 1 of your VAT return.
Countering arrangements designed to take advantage of the VAT rate changeIn order to counter businesses taking advantage of the VAT rate change by making arrangements that aim to apply the 17.5 per cent VAT rate to goods or services to be delivered or performed on or after 4 January 2011, anti-forestalling legislation has been introduced. Further details of this can be found in the web link below.
Further informationHMRC has published detailed guidance on the rate change, which can be found at www.businesslink.gov.uk/vatratechange/.
RCVS President, Dr Jerry Davies, has committed to prioritise the establishment of a new Audit and Risk Committee, following publication of the recommendations of a report into two overspends at the College.
Earlier this year, outgoing President Peter Jinman had announced that a review would be carried out into the circumstances that led to higher-than-expected expenditure on the College's new database and building development works in the Lower Ground Floor at Belgravia House.
The RCVS Officer team asked Professor Bill McKelvey - a member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to look at all aspects that related to its budgeting and expenditure process of those projects, and propose lessons that should be learned.
Dr Davies said: "That such a review was required is regretted, but I would like to thank Professor McKelvey, Richard Davis and Judith Webb for their diligence in this work. Their recommendations will be a very helpful addition to the work that is currently underway to ensure corporate governance is fit for purpose and, in particular, that the management of capital projects within the College is optimised."
The full Overspend Report (one sentence was redacted on legal advice) was considered by Council at its meeting on 3 November. Council agreed that the recommendations should be made public. The College is currently seeking further legal advice on whether it is proper for the report to be made available under the Freedom of Information Act.
Dr Davies added: "The recommendations of the report are under consideration by a group of five past Presidents, together with Richard Davis and Judith Webb as lay members of Council, under the Chairmanship of Peter Jinman, and their proposals will be considered by Council in due course.
"The recommendation that an Audit and Risk Committee be set up will be prioritised, as this was highlighted as an imperative. Other related activities, such as the development of a protocol for the management of major projects, had already been put in place by Officers prior to the overspend review."
Regarding the two projects at the heart of the report, the College says building work in the Lower Ground Floor at Belgravia House has been complete for some time and the new rooms and their facilities are being used, particularly when Disciplinary Committee hearings render much of the rest of the building out of bounds. The new data management system is also in use and an external consultant is currently looking at the work that has been carried out so far, and will make recommendations for the future.
"Meanwhile, although there are many lessons to be learned from the report, it's business as usual in terms of bringing to a conclusion many of our important ongoing initiatives, such as the introduction of the new Code of Professional Conduct, the consultations on the recommendations of the Specialisation Working Party and a draft Performance Protocol, and, of course, the ongoing work of the Disciplinary and Preliminary Investigation Committees," said Dr Davies.
The recommendations of the report, which were adopted by Council, can be downloaded from www.rcvs.org.uk/McKelvey.
The British Equine Veterinary Association (BEVA) has announced that it is reducing the cost of its CPD by 50% this year and making its webinars free to members.
David Mountford, Chief Executive of BEVA said: "Last year we were able to capitalise on some efficiencies in other areas of BEVA operations. We are delighted to be able to hand the resulting benefits directly back to our members across all our CPD programme during 2013."
The Association says its CPD covers a broad range of topics is aimed at busy vets who need to build CPD points, whether new graduates, equine or mixed practitioners. It takes the form of clinical workshops, regional meetings, nursing meetings, webinars and one, two and three day practical courses, held in the UK.
This year's courses include:
For more information, visit http://www.beva.org.uk/news-and-events/beva-courses or ring +44(0)1638 723555 or email info@beva.org.uk.
The Royal College of Veterinary Surgeons has released a series of photographs taken at its last council meeting on 7th March 2013.
Anyone for a photo-caption competition?
The full album can be seen here: http://www.flickr.com/photos/rcvs/sets/72157633046308352/
Vetoquinol has launched www.epiphenonline.co.uk, to support the veterinary profession and dog owners in the management of epilepsy.
The company says it has developed the online service to complement its existing monitoring aids and booklets, and give the best possible support to vets and patients during the complex process of stabilising and managing seizures.
The online service enables owners to keep a seizure diary, and share it with their veterinary surgeon so that they can prescribe an appropriate medication and management programme.
According to Vetoquinol, approximately three to five per cent of dogs suffer from idiopathic epilepsy, (which accounts for 80 per cent of epileptic seizures). The condition is inherited in some breeds, including Beagles, Dachunds, Keeshonden, German Shepherds and Belgian Tervurens.
Documenting the animal's history and seizure activity is crucial in assessing the progression of epilepsy. It also provides invaluable information for diagnosis and maintenance of effective therapeutic control.
Avid, the maker of pet microchip indentification products has developed its registration system so that Avid MicroChips can now be registered via practice management software using the VetXML schema.
This instantly registers the microchip directly on to the UK PETtrac Database, managed by Avid. All the implanter needs to do is add the microchip number to the client record, then click to register.
The practice has the option to print a receipt for the client before they leave the surgery, and a certificate confirming the registration will be posted to the client by PETtrac, usually the same day.
The microchip registration is completed in real time on the UK PETtrac Database, and is automatically checked to ensure the microchip being registered was sold to the practice completing the registration. In the event of any errors, the practice will be contacted by PETtrac to obtain the correct information.
Simon Clark, IT developer for Avid said "Avid already has direct registration via a number of practice management software packages and we are working with others to get this feature implemented as soon as possible. Registrations are now easier and quicker than ever before, and really can be completed with just one click!"
For full details about how the Avid microchip system can benefit your practice please contact the Avid sales office on 0800 652 7 977 or visit www.avidplc.com
The Royal College of Veterinary Surgeons is calling for members to nominate veterinary surgeons and non-veterinary surgeons who merit the award of Honorary Associateship or Honorary Fellowship.
Honorary Associateships are awarded annually to people, not necessarily veterinary surgeons, by reason of their special eminence in, or special service to, the veterinary profession. Council has agreed that these should only be people ineligible for election as Honorary Fellows.
Honorary Fellowships can be awarded to up to three veterinary surgeons in any one year for their service to, or special eminence in, the cause of veterinary science.
Nominees for Honorary Fellowships must be members of the RCVS and have been a member, or held a registrable qualification, for at least 20 years.
All nominations need to include the particular reasons why the honour/award should be conferred, along with supporting statements from two referees, at least one of whom must not be a working colleague of the person nominated.
Nominations must be received by the President, Dr Jerry Davies, by Friday, 2 September 2011.
Members may download the nomination form, or request it from the RCVS Executive Office (0207 202 0761 or executiveoffice@rcvs.org.uk).
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
“Assessment of the clinical usefulness of ultrasound-guided cytological specimens obtained from gastrointestinal lesions in dogs and cats” retrospectively reviewed GI cytological samples obtained by ultrasound-guided FNCB of 25 dogs and 19 cats from a single institution between February 2014 to August 2016.
The aim of the study was to assess factors that may influence the clinical usefulness of submitted cytological samples collected from gastrointestinal lesions by ultrasound-guided percutaneous FNCB. Ultrasound-guided FNCB included a combination of FNI (non-aspiration) and FNA techniques, as the specific technique could not be determined retrospectively.
Clinical records were evaluated to obtain historical data, clinical findings, diagnostic results and patient outcomes. Clinically useful samples were defined as smears with sufficient cell yield and preservation to allow at least a tentative cytological diagnosis of the lesion character or pathological process.
Factors that may have influenced the retrieval of a clinically useful sample were assessed and included lesion location, sonographic lesion thickness, loss of or alteration to intestinal layer conspicuity on ultrasound, and the number of slides submitted to the cytologists. The thickness of lesions was further categorised as either a mass (≥20 mm thickness) or a thickening (<20mm).
Nick Hicks, HSBC’s Corporate Area Director in Thames Valley, said: "HSBC has enjoyed a highly effective and longstanding business relationship with Medivet, which went from the purchase of a small veterinary practice in Hendon, North London in 1987, to the acquisition of over 140 practices across the UK today. This latest financing package supports the continuing expansion strategy of this successful and acquisitive business."
Dr Arnold Levy (pictured right), Chief Executive Officer at Medivet, said: "This is the second wave of our acquisition strategy which will see us, as a privately owned company, expand our offering of veterinary practices across the country. Following the success of last year’s acquisitions, which were also funded by HSBC, we have continued our expansion across the UK a lot quicker than anticipated. This is significant progress for our business and testament to our strong financial backing."
The initiative was set up in 2014 by Mark Hirschel and Jo Amit, the co-founders of pet product company HOWND. It gained momentum last year when Ricky Gervais lent his support.
Jo said: "We have always brought our dogs Roxy and Laila to work with us, but when we moved into new offices back in 2014 we discovered that they weren’t allowed in the premises.
"This inspired us to create an event that publicised why dogs can make a positive difference in safe work environments, in attempt to encourage companies across the UK to adopt dog friendly policies.
"We’re overwhelmed with how successful Bring Your Dog To Work Day has become. It’s been amazing to see how many people have posted their dogs at work across all social media in 2014 and 2015. Most importantly, it was fantastic to raise money for a cause that has always been close to our hearts - the wonderful work of All Dogs Matter. We’re hopeful that this year will prove even more popular, building on the momentum of 2015."
The organisers point to an American study published in 2012 which concluded that dogs at work may make a positive difference by reducing stress levels in staff and increasing their levels of job satisfaction.
For more information, visit: https://bringyourdogtoworkday.co.uk
Survey forms are available from Boehringer Ingelheim Territory Managers or the survey can be completed online at https://bovikalc.typeform.com/to/jVGllV.
There will be a prize draw amongst the completed entries for 20 Bovikalc metal applicators, outers or gilets.
The survey will try and assess the scale of the hypocalcaemia problem on dairy and beef farms as well as look at the impact it has on the farm and productivity.
Boehringer says milk fever is currently thought to affect between 4-9% of the UK’s dairy cows, with the subclinical form affecting up to 39%.1,2
The survey will provide another up-to-date figure to compare with existing data and look at any regional trends that might exist.
Farmers are being encouraged to complete the survey regardless of whether they believe milk fever is an issue on their farm or not.
Bovikalc Brand Manager, Mathieu Maignan said: "We are really keen to find out about the real-life experience of milk fever and what really matters to farmers so that we can use this knowledge to improve the approach to managing the condition."
Kath Aplin, Veterinary Adviser at Boehringer Ingelheim (pictured right), is hoping to find out more about the recognition of the signs of subclinical milk fever in particular. She said: "Milk fever is not always well recognised by farmers as a predisposing factor in a number of conditions associated around transition, in particular. It will be really interesting to see if they feel there is a connection between those conditions and low calcium levels and how this affects which animals they target with calcium supplementation and other interventions."
The survey will run until 31st August 2019. The results will be shared with the farming and veterinary community alongside any insights gained into ways to improve the approach to milk fever.
References
The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
The 10 minute survey seeks to capture the current level of understanding and feelings around the deployment of AI tools across the veterinary industry.
VetCT says the purpose of the survey is to start some discussion and identify areas where training and support could help veterinary practitioners.
Julien Labruyère, Chief Innovation Officer at VetCT (pictured), said: “AI is here to stay and will increasingly become part of all aspects of veterinary medicine.
"Indeed, it’s vital to help us solve some of the workforce pressures the profession is facing globally.
"We will increasingly be using the outputs of AI tools to inform our clinical decisions, and yet the mechanisms and algorithms can be something of a black box of mystery.
“We want to understand the needs of clinicians in understanding how to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"The results will be published and freely accessible.
"Our hope is to encourage a collaborative effort to support veterinary teams with embracing the full potential of AI, yet also providing the safeguards and education to the clinicians applying this technology to their patients.”
The survey is here: https://bit.ly/VetCT_AI_Survey.
For the research, Purina questioned 1535 current and potential dog owners using validated scales assessing depression, anxiety, happiness, attitude and commitment toward their pet, and perceived social support.
67% of participants said they felt that COVID had had an emotional impact on them.
One-third of participants also felt that their health had been impacted by the pandemic, while 45% had experienced a financial impact.
However, it was found that dog owners had higher perceived level of social support and lower depression scores.
Francois Martin, M.A., Ph.D., applied behaviour and welfare research section leader at Purina and lead Purina scientist on the project said: "Our research showed that dog owners fared better from a social support and emotional standpoint during COVID than people who like dogs but didn’t own one during the pandemic.
"Our work adds to a growing body of evidence demonstrating the power of the human pet bond, especially in times of stress.”
Libby Sheridan MVB MRCVS, Purina Scientific Affairs Manager for the UK and Ireland said: "The research aimed to build on prior evidence that suggests that dogs can contribute to their owner’s positive affective state - a psychological term describing when people are in generally positive frame of mind like excited, enthusiastic, and inspired.
"Purina also set out to gain a better understanding of whether the power of the pet-owner bond continued to persist during the pandemic. Not only was the effect of dogs shown to be positive, it was also measurable and statistically significant.”
Purina says the results also provide an opportunity to reflect on the important contribution of veterinary professionals, many of whom continued to work throughout the pandemic to provide much needed services.
For full results, visit: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260676
Jonathon is an RCVS & EBVS European Specialist in Veterinary Diagnostic Imaging, with a particular interest in MRI of the distal limb and has published scientific work on this subject, among others.
With the increase in availability and accessibility to CT for horses, VetCT says this hot topic will be well received by equine vets at all levels of experience.
VetCT’s Equine Teleradiology Manager, Charlotte Graham, said: “We can guarantee a highly engaging talk with plenty of useful tips on case selection for each modality as well as some interesting discussions in the Q&A session.”
To register for the webinar on 18th April and receive links to recordings of this and previous webinars in the 2023 series, sign up here: https://vetct.zoom.us/webinar/register/WN_zkctYZYWRUmRVIFTxrvvsA
www.vet-ct.com
Vetoquinol, makers of Sedalin (acepromazine), has published a free clipping guide for horse owners.
The company says the launch of the guide has been timed to coincide with the horse clipping season, when owners may be considering sedating horses to make things safer for themselves and their horses.
The guide refers owners to their veterinary surgeon for professional advice if sedation is appropriate.
The company has also produced promotional practice posters: ' Less Stress more Success'
For your poster and accompanying guides, contact your Vetoquinol Territory Manager or Teleservices directly on 01280 825424. You may also wish to put a link to a downloadable version of the guide on your practice website: http://www.vetoquinol.co.uk/clippingguide.pdf
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
Goddards, the Greater London-based 46-branch, 3 hospital veterinary group has announced the move of its HQ to a new premises in a former police station in Woodford Green, Essex.
Twenty staff from the practice, including senior managers, the accounts and IT teams and the ProActive Pets Wellness Club, are now based at the new premises.
PC Philip Goddard of Woodford Green said: "After 60 years working within our hospital in Wanstead, our support teams had outgrown the office space available. The move provides a greatly enhanced working environment for them and has also freed up space in the hospital that will be used to improve facilities for staff there, including a new lecture room for our Nursing College and Training Department."
The new address is: Claygate House, Manor Road, Woodford Green, Essex IG8 8BX. Telephone: 020 8506 0703.
World Horse Welfare and Federation of European Equine Veterinary Associations (FEEVA) have announced the publication of a new set of practical guidelines on assessing the fitness for transport of equidae (horses, ponies, donkeys and their hybrids).
The publication was produced by a collaboration of agri-food, transport, veterinary organisations and animal welfare groups supported by the European Commission.
The guidelines are designed to set out clear and simple methods of assessing the fitness of equidae for transport to support a number of objectives including: helping maintain good health among animals and humans, reducing the risk of disease transmission and preventing animal suffering. The guidelines also support transporters in avoiding penalties, financial losses, and withdrawal of the transporter’s authorisation or driver’s certificate of competence.
The guidelines also offer a health and transport checklist and a quick reference guide to assess vital signs and health concerns.
Whilst the guidelines have been produced to protect animal welfare, they also aim to help protect the health and safety of anyone involved in the transport of equidae, supporting transport professionals in the enforcement and understanding of EU Regulation 1/2005 which states that 'No animal shall be transported unless it is fit for the intended journey'.
Andrea Gavinelli, Head of Unit for Official Controls and Eradication of Diseases in Animals, said: "These guidelines will be an essential resource for anyone involved in the transportation of horses, donkeys, mules or their hybrids and I am pleased that the Commission has been able to support their production and dissemination."
The guidelines also received recognition from Dr Bernard Vallat Director General of the World Organisation for Animal Health (OIE) for 15 years before recently leaving the position. He said: "It is my pleasure to commend this visual guide to health conditions that may impact on the fitness of animals to travel. This clear and simple guide will help all those involved in animal transport to quickly and easily assess the situation and understand what course of action to take."
The guidelines are available by registering via FVE (Federation of Veterinarians of Europe) www.fve.org
The recommendation follows the analysis of data collected as part of the company's Talk About Laminitis disease awareness initiative, which has seen more than 47,000 horses tested for PPID since it was launched in 20121.
The data revealed that, regardless of presenting clinical signs, a horse aged 15-20 is three times more likely to have PPID compared to a horse under 10, and this risk increases with age. For example, a horse of 20-25 is six times more likely to have PPID compared to a horse under 10 and a horse that is 25-30 is 10 times more likely to have PPID.
Boehringer says that despite the high prevalence of PPID in the older horse population, the clinical signs of the disease are insidious in onset and owners may simply associate them with the ageing process.
One study demonstrated that in a single population of horses over the age of 15 only 1.6% of owners reported signs of PPID2. However, when the same group of horses were examined by a veterinary surgeon, 21% were found to have signs of the disease.
Dr Jo Ireland, veterinary surgeon at the University of Liverpool, said: "It is often difficult for owners to spot the signs of PPID as they frequently associate them with the ageing process. However, PPID is now the fifth most commonly diagnosed disease in horses in the UK3.
"We are therefore encouraging veterinary surgeons to routinely test horses over 15 years of age or those that are displaying signs of PPID with an ACTH test."
The 'Talk About Laminitis' disease awareness initiative runs from June until the end of October and aims to raise awareness of the underlying hormonal causes of laminitis – PPID and Equine Metabolic Syndrome (EMS). As part of the scheme, the laboratory fees for the blood test which detects PPID (the basal ACTH test) are free.
Redwings’ head of veterinary and care, senior veterinary surgeon Nicky Jarvis, said: "Any initiative that decreases the incidence of laminitis developing in an older equine is invaluable. Laminitis is an extremely distressing condition for both the horse and the owner and the long-term consequences can be devastating. Knowing the underlying cause is a huge help in tackling the disease and we would encourage anyone to take advantage of this offer and get their veteran checked out."
For further information about 'Talk About Laminitis', visit www.talkaboutlaminitis.co.uk or contact your local Boehringer Ingelheim account manager.
The recall is for the following batches only:
Petlife is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Dr J M Ballany on +44 1333 720257 or email: johnballany@btinternet.com.